Item 5.07 Submission of Matters to a Vote of Security Holders.

On August 23, 2022, the 2022 Annual Meeting of Stockholders (the "2022 Annual Meeting") of Adhera Therapeutics, Inc. (the "Company") was held following an adjournment from its originally scheduled date of August 18, 2022. At the 2022 Annual Meeting, the Company's stockholders voted on (i) the election of four members of the Company's Board of Directors for a one-year term expiring at the next annual meeting of stockholders (Proposal 1); (ii) ratification of the selection of Salberg & Company as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022 (Proposal 2); (iii) approval of an amendment to the Certificate of Incorporation of the Company to effect a reverse stock split of all issued and outstanding shares of the Company's common stock, par value $0.006 per share, at a ratio to be determined in the discretion of the Company's Board of Directors within a range of one-for-two through one-for-200, provided that in no event shall such amendment collectively exceed a reverse stock split ratio of one-for-200 (Proposal 3); and (iv) approval of an adjournment of the 2022 Annual Meeting to a later date or time, if necessary, to permit further solicitation and vote of proxies if there are not sufficient votes at the time of the 2022 Annual Meeting to approve any of the proposals presented for a vote at the 2022 Annual Meeting, all as described in more detail in the Company's definitive proxy statement filed with the Securities and Exchange Commission on June 27, 2022.

Set forth below are the voting results on each matter submitted to the stockholders at the 2022 Annual Meeting.





Proposal 1. The Company's stockholders voted to elect the following four
individuals as directors to hold office until the next annual meeting of
stockholders:



       Nominee          Votes For    Votes Withheld   Broker Non-Votes
Mr. Trond Waerness      31,668,343      997,471          3,149,780
Mr. Andrew Kucharchuk   31,668,353      997,461          3,149,780
Mr. Charles Rice        31,668,792      997,022          3,149,780
Mr. Zahed Subhan        31,668,350      997,464          3,149,780

Proposal 2. The Company's stockholders voted to ratify the selection of Salberg & Company as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022.





Votes For    Votes Against   Abstentions
34,941,682      760,243        113,669

Proposal 3. The Company's stockholders voted to approve an amendment to the Certificate of Incorporation of the Company to effect a reverse stock split of all issued and outstanding shares of the Company's common stock, par value $0.006 per share, at a ratio to be determined in the discretion of the Company's Board of Directors within a range of one-for-two through one-for-200, provided that in no event shall such amendment collectively exceed a reverse stock split ratio of one-for-200.





Votes For    Votes Against   Abstentions
33,298,980     2,434,230       82,384

As there were sufficient votes to approve proposals 1 through 3, proposal 4 was moot.

© Edgar Online, source Glimpses